HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anil K Jaiswal Selected Research

Breast Neoplasms (Breast Cancer)

11/2018Retraction: Aromatase Inhibitor-mediated Downregulation of INrf2 (Keap1) Leads to Increased Nrf2 and Resistance in Breast Cancer.
7/2015Aromatase Inhibitor-Mediated Downregulation of INrf2 (Keap1) Leads to Increased Nrf2 and Resistance in Breast Cancer.
10/2012The importance of HER2 signaling in the tumor-initiating cell population in aromatase inhibitor-resistant breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anil K Jaiswal Research Topics

Disease

20Neoplasms (Cancer)
01/2023 - 12/2002
8Carcinogenesis
05/2022 - 11/2002
8Visceral Leishmaniasis (Kala Azar)
12/2017 - 02/2012
7Hyperplasia
11/2018 - 06/2002
6Leishmaniasis
11/2016 - 03/2014
5Infections
01/2021 - 11/2002
4Hepatocellular Carcinoma (Hepatoma)
03/2012 - 10/2009
4Hepatoblastoma
03/2012 - 03/2002
3Breast Neoplasms (Breast Cancer)
11/2018 - 10/2012
2Carcinoma (Carcinomatosis)
01/2023 - 10/2007
2Inflammation (Inflammations)
01/2019 - 07/2009
2B-Cell Lymphoma (Lymphoma, B Cell)
11/2018 - 03/2009
2Parkinson Disease (Parkinson's Disease)
02/2008 - 10/2004
2Leukemia
03/2003 - 06/2002
2Poisoning
03/2003 - 06/2002
1Head and Neck Neoplasms (Head and Neck Cancer)
12/2022
1Asthma (Bronchial Asthma)
01/2019
1Metaplasia
01/2019
1Scrub Typhus (Typhus, Scrub)
01/2018
1Hemolysis
12/2017
1Communicable Diseases (Infectious Diseases)
04/2015
1Interstitial Cystitis (Interstitial Cystitis, Chronic)
11/2012
1Tics (Tic)
10/2012
1Lung Neoplasms (Lung Cancer)
03/2012
1Necrosis
02/2012
1Respiratory Hypersensitivity
07/2009

Drug/Important Bio-Agent (IBA)

20quinone (benzoquinone)IBA
05/2022 - 06/2002
19Oxidoreductases (Dehydrogenase)IBA
05/2022 - 06/2002
12NRH - quinone oxidoreductase2IBA
11/2018 - 11/2002
9Amphotericin B (Amphotericin)FDA LinkGeneric
12/2017 - 04/2013
9Proteins (Proteins, Gene)FDA Link
07/2015 - 06/2002
7NAD (NADH)IBA
11/2018 - 06/2002
5Benzo(a)pyreneIBA
05/2022 - 09/2004
4CytokinesIBA
01/2019 - 05/2006
4ChitosanIBA
12/2017 - 04/2013
4QuinonesIBA
07/2006 - 12/2002
3Aromatase InhibitorsIBA
11/2018 - 10/2012
3NanocapsulesIBA
08/2015 - 04/2013
3AntioxidantsIBA
04/2013 - 03/2011
3Etoposide (VP 16)FDA LinkGeneric
04/2013 - 03/2011
3EnzymesIBA
02/2010 - 11/2002
3Benzene (Benzole)IBA
05/2005 - 06/2002
29,10-Dimethyl-1,2-benzanthraceneIBA
05/2022 - 09/2004
2Immunologic Adjuvants (Immunologic Adjuvant)IBA
10/2014 - 04/2013
2Small Interfering RNA (siRNA)IBA
04/2013 - 08/2011
2CarcinogensIBA
02/2010 - 09/2004
2NADP (NADPH)IBA
11/2009 - 03/2003
2DNA (Deoxyribonucleic Acid)IBA
02/2008 - 10/2007
2Vitamin K 3 (Menadione)FDA Link
07/2006 - 11/2002
2hydroquinone (Esoterica)FDA Link
08/2002 - 03/2002
1Cisplatin (Platino)FDA LinkGeneric
12/2022
1AntibodiesIBA
10/2021
1Immune Checkpoint InhibitorsIBA
10/2021
1Interferon LambdaIBA
01/2021
1Methacholine Chloride (Methacholine)FDA Link
01/2019
1Dimethyl FumarateIBA
01/2019
1Immunoglobulin M (IgM)IBA
01/2018
1MicellesIBA
12/2017
1SuspensionsIBA
12/2017
1calcium phosphateIBA
11/2016
1Doxorubicin (Adriamycin)FDA LinkGeneric
08/2015
1Mannose (D-Mannose)IBA
08/2015
1ChondroitinIBA
08/2015
1Hormones (Hormone)IBA
07/2015
1AlginatesIBA
05/2015
1StearatesIBA
05/2015
1glycol-chitosanIBA
05/2015
1lipoteichoic acidIBA
04/2015
1LactoferrinIBA
01/2015
1Lipid NanoparticlesIBA
10/2014
1LectinsIBA
06/2014
1Mitogen Receptors (Mitogen Receptor)IBA
06/2014
1Transcription Factors (Transcription Factor)IBA
02/2013
1Estrogen ReceptorsIBA
10/2012
1Letrozole (Femara)FDA LinkGeneric
10/2012
1Phosphotransferases (Kinase)IBA
10/2012
1ErbB Receptors (EGF Receptor)IBA
10/2012
12-tert-butylhydroquinone (tert-butylhydroquinone)IBA
03/2012
1Interleukin-12 (IL 12)IBA
02/2012
1Interleukin-10 (Interleukin 10)IBA
02/2012
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
02/2012
1Nitric Oxide (Nitrogen Monoxide)FDA Link
02/2012
1miltefosine (Impavido)IBA
02/2012
1InterferonsIBA
02/2012
1Transforming Growth Factors (Transforming Growth Factor)IBA
02/2012
1Interleukin-4 (Interleukin 4)IBA
02/2012
1anthraceneIBA
02/2010
1phorbolIBA
02/2010
1Methylnitronitrosoguanidine (MNNG)IBA
11/2009
1Aryl Hydrocarbon Receptor Nuclear TranslocatorIBA
11/2009
14-hydroxy-2-nonenal (4-hydroxynonenal)IBA
10/2009
1OzoneIBA
07/2009
1ChemokinesIBA
07/2009
1IsoprostanesIBA
07/2009
18-epi-prostaglandin F2alphaIBA
07/2009

Therapy/Procedure

7Drug Therapy (Chemotherapy)
12/2017 - 04/2013
4Therapeutics
10/2021 - 10/2012
2Immunotherapy
08/2015 - 10/2014
1Brachytherapy
01/2023
1Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
12/2022